Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of combination therapy
with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's
lymphoma.